Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis (Q35654035)

9 August 2017

title

Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis (English)

1 reference

9 August 2017

0 references

Brucella melitensis

1 reference

Ariza J

1

1 reference

9 August 2017

Bosch J

2

1 reference

9 August 2017

Gudiol F

3

1 reference

9 August 2017

Liñares J

4

1 reference

9 August 2017

Viladrich PF

5

1 reference

9 August 2017

Martín R

6

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 December 1986

1 reference

Antimicrobial Agents and Chemotherapy

9 August 2017

published in

1 reference

9 August 2017

volume

30

1 reference

9 August 2017

issue

6

1 reference

9 August 2017

page(s)

958-960

1 reference

Intracellular Production of Brucella L Forms I. Recovery of L Forms from Tissue Culture Cells Infected with Brucella abortus.

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180631

The protection of intracellular brucella against therapeutic agents and the bactericidal action of serum

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180631

In vitro activity of N-formimidoyl thienamycin against 98 clinical isolates of Brucella melitensis compared with those of cefoxitin, rifampin, tetracycline, and co-trimoxazole

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180631

In vitro development of rifampin resistance in clinical isolates of Haemophilus influenzae type b.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180631

In vitro susceptibility of Brucella to various antibiotics

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180631

Intracellular production of Brucella L forms . II. Induction and survival of Brucella abortus L forms in tissue culture

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180631

Effects of chlortetracycline on intracellular Brucella

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180631

Brucellosis in the United States, 1960-1972. An abattoir-associated disease. Part I. Clinical features and therapy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180631

Comparative trial of rifampin-doxycycline versus tetracycline-streptomycin in the therapy of human brucellosis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180631

Effect of Rifampin on Nasal Carriage of Staphylococcus aureus

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180631

Rifampin in the treatment of experimental brucellosis in mice and guinea pigs

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180631

Laboratory diagnosis of brucellosis in man.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180631

Human brucellosis: an evaluation of antibiotics in the treatment of brucellosis

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180631

In vitro susceptibility of Brucella melitensis to new cephalosporins crossing the blood-brain barrier

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180631

Treatment of Brucella canis and Brucella abortus in vitro and in vivo by stable plurilamellar vesicle-encapsulated aminoglycosides

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180631

The protection of intracellular brucella against streptomycin alone and in combination with other antibiotics

25 September 2018

1 reference

12 December 2020

Determination of the in vitro sensitivity of Brucella strains to rifampicin

1 reference

12 December 2020

The rose bengal plate agglutination test in the diagnosis of brucellosis

1 reference

12 December 2020

Follow-up study of therapy in forty-eight culturally proved cases of brucellosis; streptomycin and sulfadiazine, aureomycin, and chloramphenicol (chloromycetin)

1 reference

12 December 2020

Relation between complement fixation and incomplete antibodies (Coombs' test) in human brucellosis

1 reference

12 December 2020

The sensitivity of Brucella abortus to chemotherapeutic agents

1 reference

12 December 2020

Comparative trial of co-trimoxazole versus tetracycline-streptomycin in treating human brucellosis

1 reference

12 December 2020

Effect of rifampicin and tetracycline alone and in combination against Brucella suis

1 reference

12 December 2020

The treatment of brucellosis using rifampicine (author's transl)

1 reference

12 December 2020

HOST-PARASITE RELATIONSHIP IN BRUCELLOSIS

1 reference

12 December 2020

Some biologic and clinical problems related to intracellular parasitism in brucellosis

1 reference

12 December 2020

In-vitro activity of ciprofloxacin, ceftriaxone and five other antimicrobial agents against 95 strains of Brucella melitensis

1 reference

12 December 2020

Persistent parasitism in experimental brucellosis: attempts to eliminate brucellae with long-term tetracycline therapy

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.30.6.958

1 reference

9 August 2017

1 reference

9 August 2017

1 reference